Challenging Assumptions About Minority Participation in US Clinical Research

Although extensive research addresses minorities’ low participation in clinical research, most focuses almost exclusively on therapeutic trials. The existing literature might mask important issues concerning minorities’ participation in clinical trials, and minorities might actually be overrepresent...

Ausführliche Beschreibung

Gespeichert in:
Bibliographische Detailangaben
Veröffentlicht in:American journal of public health (1971) Jg. 101; H. 12; S. 2217 - 2222
Hauptverfasser: Fisher, Jill A., Kalbaugh, Corey A.
Format: Journal Article
Sprache:Englisch
Veröffentlicht: Washington, DC American Public Health Association 01.12.2011
Schlagworte:
African Americans
African Americans - statistics & numerical data
Biological and medical sciences
Biomedical research
Clinical research
Clinical trials
Clinical Trials as Topic - statistics & numerical data
Clinical Trials, Phase I as Topic
Clinical Trials, Phase III as Topic
Disenfranchisement
Elimination
Equality
Ethics
Ethics, Research
General aspects
Health care
Hispanic Americans
Hispanic Americans - statistics & numerical data
Human subjects
Humans
Literature
Medical research
Medical sciences
Minority & ethnic groups
Minority groups
Minority Groups - statistics & numerical data
Minority set aside programs
Miscellaneous
Participation
Patient Participation - statistics & numerical data
Patient Selection
Public health
Public health. Hygiene
Public health. Hygiene-occupational medicine
Syphilis
United States
Volunteers
Winning Policy Change
Womens health
United States
North America
America
Participation
Clinical research
Minority
Public health
ISSN:0090-0036, 1541-0048, 1541-0048
Online-Zugang:Volltext
Tags: Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!
Beschreibung
Zusammenfassung:Although extensive research addresses minorities’ low participation in clinical research, most focuses almost exclusively on therapeutic trials. The existing literature might mask important issues concerning minorities’ participation in clinical trials, and minorities might actually be overrepresented in phase I safety studies that require the participation of healthy volunteers. It is critical to consider the entire spectrum of clinical research when discussing the participation of disenfranchised groups; the literature on minorities’ distrust, poor access, and other barriers to trial participation needs reexamination. Minority participation in clinical trials is an important topic in public health discussions because this representation touches on issues of equality and the elimination of disparities, which are core values of the field.
Bibliographie:ObjectType-Article-1
SourceType-Scholarly Journals-1
ObjectType-Feature-2
content type line 14
content type line 23
The authors contributed equally to the development and writing of this article.
Contributors
ISSN:0090-0036
1541-0048
1541-0048
DOI:10.2105/AJPH.2011.300279